and over short and long follow-ups , with the longest follow-up period being over 40 years , Several mechanisms have been 2 -7 2 8 proposed to explain these associations , including smoking, age-related chronic conditions, and inflammation. However, the 5 9 -11 relative importance of different mechanisms remains unclear as few studies have been able to use a comprehensive range of explanatory risk factors within a single methodological set up. The objective of the present study is therefore to examine the extent to which socioeconomic factors, health behaviors, cardiovascular risk factors and diseases, and inflammatory markers explain the association between lung function and all-cause mortality.
MATERIALS AND METHODS

Study population
Data are drawn from the Whitehall II study established in 1985 as a longitudinal study on 10,308 civil servants (6, 895 
Lung function
Lung function was measured using a portable flow spirometer (MicroPlus Spirometer, Micro Medical Ltd, Kent, UK), administered by a trained nurse. Participants with the following conditions were allowed to opt out of lung function tests: recently been coughing up blood of unknown origin, ever had a pneumothorax, severe angina requiring hospitalization in the previous 6 months, ever had a heart attack or stroke, ever had a pulmonary embolism or an aneurysm, recent ear or eye surgery, recent stomach or chest surgery, ever suffered with a perforated ear drum or hernia, and blood pressure higher than 180/96 mmHg on the day. Thus, 4,832 (74. 
Mortality
A total of 10,297 respondents (99.9 ) were successfully traced for mortality through the national mortality register kept by the were drawn from questionnaires at Phases 1, 3, 5, and 7.
was assessed using questions on smoking Health behaviors
Smoking history status and current amount of tobacco smoked categorized as current smoker at Phase 7 , recent ex-smoker (those who stopped smoking
between Phases 1 and 7), long-term ex-smoker (those who stopped smoking before Phase 1), and never smoker . The current smoker
category was further divided into three groups according to the number of cigarettes smoked per day: less than 10, between 10 and 20, and more than 20. was assessed via questions on the number of alcoholic drinks ( measures of spirits, glasses of wine, Alcohol consumption
and pints of beer) consumed in the last seven days. This was converted to number of units (1 unit 8 grams) of alcohol. The
was assessed on an 8-point scale, ranging from seldom or never to two or more times a day . fruit and vegetable consumption " " " " The was calculated from a question on the number of hours of physical number of hours of moderate and vigorous physical activity per week activity at different levels at Phases 1 and 3, and from a 20-item questionnaire on the frequency and duration of participation in walking, cycling, sports, gardening, housework, and home maintenance, at Phases 5 and 7
. Summary measures of these health behaviors over 14 the four phases were used in the present analysis; smoking history as defined above, and for the other health behavior measurements mean values over the four phases.
(BMI) at Phase 7 was calculated as weight divided by height squared (kg/m ). Weight was measured in underwear Body mass index 2 to the nearest 0.1 kg using an electronic Soehnle scale with a digital readout (Leifheit AS, Nassau, Germany). Height was measured in bare feet to the nearest millimetre using a stadiometer with the participant standing completely erect with the head in the Frankfort plane. BMI was categorized as: BMI<20, BMI 20.0 24.9, BMI 25 29.9, and BMI 30.
included in the analysis were serum cholesterol, systolic and diastolic blood pressure, and were measured Cardiovascular risk factors during the clinical examination at Phases 1, 3, 5, and 7. Blood pressure was measured twice with the participant sitting after a 5-minute rest using the Hawksley random-zero sphygmomanometer. The average of two readings was taken to be the measured blood pressure.
Serum cholesterol was measured within 72 hours in serum stored at 4 C using enzymatic colorimetric methods. As for the health°b ehaviors, the mean of these measures over the four phases of data collection (Phases 1, 3, 5 and 7) was used to reflect history of these risk factors in the analysis.
included prevalence of coronary heart disease (CHD), stroke, and diabetes. CHD prevalence was based on Chronic conditions clinically verified events and included myocardial infarction and definite angina . Stroke was assessed using a self-reported measure of 15 physician diagnosis. Diabetes was defined by a fasting glucose 7.0 mmol/L or a 2-hour postload glucose 11.1 mmol/L or reported doctor ≥ ≥ diagnosed diabetes, or use of diabetes medication . 16 included interleukin-6 (IL-6) and C-reactive protein (CRP), assessed at Phases 3 and 7. During the clinical Inflammatory markers examination fasting serum was collected and was stored at 70 C until analysis. Samples from both phases were analysed at the same −° time. CRP was measured using a high-sensitivity immunonephelometric assay in a BN ProSpec nephelometer (Dade Behring, Milton Keynes, UK). IL-6 was measured using a high-sensitivity ELISA assay (R & D Systems, Oxford, UK)
. As the distributions of CRP 17 and IL-6 were skewed, they were log-transformed for the analysis. The mean of the Phases 3 and 7 measures was used in the analysis.
Statistical analysis
FEV divided by height squared was used in the analysis as it adjusts the lung function measure for body size and has been shown to 1 be a good predictor of mortality , . We also examined the associations with FVC/height and FEV percent of the predicted value (FEV 4 6 2 1 pred) and report these results briefly. As the distribution of the lung function differs by sex, we used sex-specific tertiles of the lung 1 % function measures in the analyses.
We first assessed the differences in all covariates between those who were alive and those who had died at the end of the follow-up period using t-tests for continuous variables and chi-square tests for categorical variables. We also investigated the association between sex-specfic tertiles of FEV /height and covariates using linear regression for continuous variables and logistic regression for dichotomous 1 2 variables.
In order to examine the relationship between lung function and mortality graphically over the follow-up period, unadjusted and fully adjusted survival curves were plotted for tertiles of FEV /height , . Subsequently, Cox regression with age as time-scale was used to 1 2 18 estimate Hazard Ratios (HR) and their 95 percent confidence intervals (CI) for the association between the tertiles of lung function and mortality. The proportional hazards assumption for the Cox model was confirmed formally by the Shoenfeld s tests.
'
As no difference of risk was found between the two upper tertles of FEV /height , the results show the HR of mortality associated 1 2 with being in the lower FEV /height compared to that in the upper two tertles of FEV /height . We first examined the extent to which 1 2 1 2 this association was explained by smoking history. In order to do this, we added smoking history to the model including age and sex (model 1). The reduction in model 1 attributed to smoking history was calculated using the formula 100 (
) . Subsequently, the extent to which this association was attenuated was examined by adding socioeconomic position, other
health behaviors and BMI, cardiovascular risk factors, chronic diseases, and inflammatory markers, sequentially and then all covariates simultaneously to the model adjusted for age, sex and smoking history (model 2). The reduction in model 2 attributed to the group of covariates under consideration was calculated using the formula 100 ( )/( ) . All analyses were repeated
using FVC/height instead of FEV /height as the measure of lung function. We also undertook analysis using FEV pred, computed The main analysis was performed using the statistical software STATA 10, StataCorp LP, Texas, USA. Adjusted survival curves were calculated using the statistical software SAS 9 and the macro proposed by Cole and colleagues.18
RESULTS
Sample description
A total of 4,817 participants with complete data on lung function and all covariates were included in the analysis; 139 died during a .001) although not lung cancer (3 cases in study participants vs. 0 case in others). % P % % P This group was also younger (60.8 vs. 61.9 years, <0.001), composed of fewer current smokers (7.3 vs 9.2 , <0.001) but showed no P % % P difference in self-reported history of asthma (9.9 vs. 10.0 , 0.96).
presents characteristics of the study participants as a function of the vital status at the end of follow-up. shows that Table 1  Table 2 there was a linear association between all the covariates and the sex-specific tertiles of FEV /height ( 0.005). 721 (15.0 ) of the 4,817 result, we combined the top two tertiles in subsequent analyses. shows unadjusted and fully adjusted survival curves using Figure 1 4 10 sex-specific tertiles of FEV /height . As is clear from the figure, a difference in probability of survival between these two groups started 1 2 to appear after approximately 18 months of follow-up and persisted over the rest of the follow-up. The dotted line in the figure shows the attenuation in the association with the addition of covariates to the model. presents the adjustment for covariates in greater detail. In model 1, adjusted for age and sex, being in the lower tertile of FEV this association in addition to the 3.7 explained by smoking history, with inflammatory markers leading to the greatest attenuation in the % association (28.0 ). The analysis using FEV pred (online supplement Web Table 1 ) showed being in the lowest tertile to be associated
with a 1.55-fold (95 CI: 1.11 2.17) higher risk of mortality compared to the top two tertiles. Here again, inflammation markers explained % -the greater part of the association (33.9 ).
%
We also undertook analyses using cause-specific mortality but due to the small number of deaths these analyses are restricted to cardiovascular (N 35) and cancer (N 68) mortality. Those in the lowest FEV/height tertile had greater risk of cardiovascular (HR 1.90; 
Sensitivity analysis
We performed further analyses in several subgroups in order to ascertain the robustness of our findings. The analyses were repeated among never smokers (N 2,422, Web Table 2) , those without a self-reported history of asthma (N 4,336, Web Table 3 ), in groups with = = FEV/FVC<70 (N 721, Table S4 ) and 70 (N 4096, Web Table 4 ). Also, analyses excluding participants in the lowest tertile of the
fat-free-mass distribution (N 2,842, Web Table 5 ) and separately on those with BMI<30kg/m (N 3976, Web Table 6 ) and 30kg/m (N
841, Web Table 6 ) yielded results largely similar to those in the main analysis. Further analyses (Web Table 7 ) excluding deaths from respiratory diseases (N 2) and lung cancer (N 1) in the first two years of follow-up also support our main findings. Finally, we examined = = the role of the explanatory variables by excluding participants with CRP level greater than 10 mg/L (Web Table 8 ) to rule out the influence of infection on the day of the examination . Here again, the results were similar to those reported in the full sample. 20
DISCUSSION
Data from a large British cohort show that poor lung function, characterised by low FEV /height , is associated with higher risk of 1 2 all-cause mortality in late midlife. Similar results were found for FVC/height and FEV pred. Socioeconomic position, health behaviors . Studies have examined changes in this association after adjusting for the effects of smoking, cardiovascular risk factors 5 9 -11 or diseases , , but to our knowledge no study has attempted to quantify the impact of a wide range of different explanatory factors 4 5 11 on the association. Lung function was once thought to reflect only smoking status which was hypothesized to explain its association with mortality. However, several studies, including our study, have shown lung function also to be related to mortality in never-smokers. , , 3 6 , , Clearly, smoking is not the only explanation of this association. Physical activity and healthier diet have also 11 22 23 24 -26 27 -29 been found to be associated with better lung function and obesity to reduced lung function . Our results show health behaviors and BMI 30
to explain approximately 10 of the association between lung function and mortality, with the effect driven mainly by smoking and % physical activity.
Am J Epidemiol . Author manuscript Page / 5 10 Other plausible explanatory factors are chronic comorbidities. This hypothesis is supported by the fact that patients with chronic obstructive pulmonary disease (COPD) die mainly from causes other than respiratory diseases ; arguing for the common cause 31
hypothesis. Ageing is accompanied by an increase in multiple chronic diseases resulting in high comorbidity at older ages, including COPD . Thus lung function might simply be a proxy for general health, explaining its association with mortality , . Another 10 5 32 possibility is that impaired lung function allows excessive quantity of inhaled environmental deleterious agents to enter the body that then lead to disease and death . In the present study, chronic diseases, such as coronary heart disease, stroke and diabetes, explained 12 of 33 % the association between FEV /height and mortality. However, our data did not allow us to distinguish between the two proposed 1 2 pathways: lung function as a proxy for general health and chronic diseases as mediating the association between lung function and mortality.
More recently, the inflammatory hypothesis has been proposed as a potential explanatory factor of the relationship between lung function and other comorbidities leading to death , . Indeed, higher levels of inflammatory markers have been found among persons 9 10 with impaired lung function , . However, it is still debated whether it is inflammation that leads to lung function deterioration or the 34 35 inverse.
, , , Inflammation is associated with several chronic conditions , such as osteoporosis, diabetes, and atherosclerosis, 10 34 36 37 10 that are all risk factors for mortality. Thus, there are some arguments in favour of a possible role of inflammatory markers in the association between lung function and mortality and our results support this hypothesis.
Nevertheless, the importance of inflammatory markers in this association may also be due to residual confounding of smoking as higher levels of inflammation are found in smokers. Furthermore, it has been suggested that inflammation leads to muscle wasting , 10 38 that is itself linked to lower lung functioning , . Our analysis based on never smokers and excluding those in the lowest tertile of the 36 39 fat-free-mass distribution showed inflammation to continue to play a role in mediating the association between lung function and mortality.
Strengths and weaknesses
The primary strength of this study is the large number of factors investigated to explain the association between lung function and mortality. Indeed, data on health behaviors and cardiovascular risk factors were available over a 15 year-period preceding the assessment of lung function. Moreover, to our knowledge, this is the first study to assess the role of inflammatory markers. A further strength of the study is the use of adjusted survival curves that allow us to summarize the data by avoiding potential weaknesses of the multiplicative model . 40
Three limitations of this study must also be noted. First, although the sample covered a wide socioeconomic range, with annual full-time salaries ranging from 4,995 to 150,000, data are from white-collar civil servants and cannot be assumed to be representative of £ £ the general population. Second, the inflammatory markers considered in our study are general markers of inflammation, included in the Whitehall II study, to assess outcomes such as cardiovascular disease and do not constitute ideal lung function markers. Third, our results " " must be interpreted with caution as the study design does not allow us to rule out the reverse causation between lung function and other covariates. Finally, these results are based on the healthier Whitehall participants, that is, those who were still alive and took part in the screening at Phase 7 of the study and who reported no contraindicative conditions against participation in the lung function tests.
Nevertheless, lower lung function still predicts mortality in this selected population and our results are likely to underestimate the true association.
Conclusions
This study is the first to investigate several potential explanations underlying the well-established association between lung function and mortality. The main finding emphasises the importance of inflammatory markers for this association. The other important explanatory factors were health behaviors and chronic diseases, such as coronary heart disease, stroke and diabetes. These results show that multiple processes are likely to link lung function and mortality.
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